Magnetically powered 'nanosperm'; Inovio announces reverse stock split;

> Scientists have developed a propulsion system that moves synthetic "nanosperms," which could someday be employed for therapeutic uses, by using a weak oscillating magnetic field. Story

> Inovio Pharmaceuticals ($INO), maker of vaccines that contain DNA plasmids, announced that its reverse stock split will become effective on June 5. Release

> By removing certain genes of the malaria parasite Plasmodium, researchers at the nonprofit Seattle BioMed believe it could become a vaccine for the disease. Story

> Aprecia Pharmaceuticals, maker of the ZipDose platform, signed an agreement with commercialization outsourcing organization inVentiv Health as it prepares for its first NDA application. Release

Suggested Articles

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.

Kindeva, which produces inhalers, transdermal patches and other medical devices, is expanding operations in the St. Paul, Minnesota, area.